Times of Israel is an online news publication that provides news and analysis on Israel, the Middle East, and the Jewish world.

Times of Israel

The Times of Israel is a Jerusalem-based news site founded in 2012 to cover Israel, the Middle East and the Jewish world.

It was established by veteran UK-born, Israeli journalist David Horovitz and his US-based capital partner Seth Klarman. Horovitz is the founding editor, responsible for the site’s editorial content.

The Times of Israel has no partisan political affiliation. It seeks to present the news fair-mindedly and offers a wide range of analysis and opinion pieces.

The Times of Israel

BeeHero, which said that its agritech is used by growers, beekeepers, agronomists, and ag retailers across the US, recently started its expansion into Australia, Europe, South Africa, and South America.

“Our platform is a crucial tool farmers can rely on to improve their crop yields,” said BeeHero CEO Omer Davidi

#bees #beetech #agtech #Israel

“#Israel is both a major stakeholder for DMCC (Dubai Multi Commodities Centre) and one of our key target markets,” said CEO Ahmed Bin Sulayem in an address at the Tel Aviv Stock Exchange this week.

There are currently 78 Israeli companies operating in the DMCC. The free trade zone offers a range of advantages, including no corporate tax, access to the Gulf market and Asia, minimal bureaucracy, and cheap labor.
#abrahamaccords #Dubai #uae #trade

“I really don’t know why it wasn’t done yet, because the benefits for medical science are very significant,” Prof. Benjamin Reubinoff of the Hadassah Medical Center told The Times of Israel's Nathan Jeffay.

Reubinoff, who led the research together with Dr. Ithai W., said that the stem cells he derived could open up a new approach to investigating illnesses and #medical #treatments.

#Israel #research #science #stemcells #medicalresearch

Rehovot-based Gadfin Aero-Logistics Systems recently inked an exclusive five-year partnership agreement with Sarel, the country’s biggest medical purchasing and logistics company, to create the first aerial drone grid that delivers urgent #medical supplies to Israeli #hospitals within 200 kilometers.

Israeli scientists produced prototypes of a small battery-powered device that fits onto a baseball cap and emits air that blows downwards in front of the face at 30 kilometers per hour (19 mph).

“We tried to quantify how many droplets still reached the face, and found that the ‘air screen’ gives high protection which is comparable to that of masks,” Moshe Shoham, professor at the Technion - Israel Institute of Technology and co-lead of the study, told The Times of Israel.

Joonko is building a network of vetted candidates with an emphasis on job-seekers from underrepresented communities, reports Shoshanna Solomon. 

Creating a diverse workforce is beneficial for company culture and helps in building innovative products, says Albrey Brown, Joonko's US general manager and VP of strategy. " It’s also the right thing to do.”

#diversity #deistrategy #diversityequityinclusion #diversityinclusion #Israel

#Israel and #Japan are advancing initial steps for the signing of a free #trade agreement in a move that is expected to bring down tariffs and lower the prices of Japanese-made cars, toys, and other imported goods. #cars #japanesecars

Cancer patients are testing a medicine made of antibodies that were designed from scratch on a computer in Israel and whose inventor has “programmed” them to “decide” whether cells surrounding tumors are bad or good.

Inventor Prof. Yanay Ofran tells TOI's Nathan Jeffay of his method and the possibilities for #cancer care and treatment.

#Israel #cancercare #cancerresearch #antibodies

Aerobic exercise makes some organs so efficient at grabbing sugar that is in the body that tumors are left starved of glucose, and often unable to grow and spread, according to a peer-reviewed study by Tel Aviv University researchers. Prof. Carmit Levy, Dr. Yftach Gepner

#Israel #cancerresearch #cancer #exercise

Tel Aviv Sourasky Medical Center says it has used an under-trial artificial intelligence technology by Israeli startup Imagene AI to give patients immediate results for a deep-dive report on their tumor’s DNA — eliminating days of waiting to get treatment for their brain cancer.

“We are so used to waiting a long time for molecular cancer testing while patients deteriorate, that such a breakthrough technology, enabling treatment initiation within a day is exceptional,” said Prof. Ido Wolf, director of the Oncology Department at Sourasky.

Imagene AI founders are Dean Bitan, Jonathan Zalach, and Shahar Porat.
#artificialintelligence #cancerresearch #cancerpatients #braintumor #Israel

COM:TIMESOFISRAEL

Times of Israel

Financials Not Available